This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Vimta Labs Limited Receives Grant in Aid for Upgrading of Food Testing Laboratory At Vimta Life Sciences Facility Plot No.5, Mn Science Technology Park, Genome Valley, Shameerpet, Hyderabad, Telangana CI
Transcript : Vimta Labs Limited, Q3 2024 Earnings Call, Feb 01, 2024
Vimta Labs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Transcript : Vimta Labs Limited, Q2 2024 Earnings Call, Oct 30, 2023
Vimta Labs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Transcript : Vimta Labs Limited, Q1 2024 Earnings Call, Jul 31, 2023
Vimta Labs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
CARE Gives A Rating to Vimta Labs' Long-term Bank Financing; Outlook Stable MT
Vimta Labs Limited Declares Dividend for the Financial Year Ended March 31, 2023 CI
Transcript : Vimta Labs Limited, Q4 2023 Earnings Call, May 05, 2023
Vimta Labs Names New Executive Chairman MT
Vimta Labs Limited Recommends Dividend for the Financial Year 2022-2023 CI
Vimta Labs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Transcript : Vimta Labs Limited, Q3 2023 Earnings Call, Jan 30, 2023
Vimta Labs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Brickwork Ratings Affirms A Rating on Vimta Labs' Bank Loans; Outlook Stable MT
Transcript : Vimta Labs Limited, Q2 2023 Earnings Call, Oct 28, 2022
Vimta Labs Logs Rise in Fiscal Q2 Consolidated Profit MT
Vimta Labs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Vimta Labs Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Vimta Labs Limited Approves Dividend for the Financial Year Ended March 31, 2022, Payable on June 30, 2022 CI
Vimta Labs Limited Recommends Dividend for the Financial Year Ended March 31, 2022 CI
Transcript : Vimta Labs Limited, Q4 2022 Earnings Call, May 13, 2022
Vimta Labs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022 CI
Vimta Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Chart Vimta Labs Limited
More charts
Vimta Labs Limited is engaged in the business of contract research and testing organization. The Company is engaged in providing a range of services to biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, power, cement, oil and gas, ores and minerals, infrastructure and many other industries, government organizations as well as other industry participants. Its services include Drug discovery, development, and drug life cycle management support services; Preclinical research and testing services for medical device companies; Contract research and testing for agrochemical and specialty chemical companies; and Food testing and analytical development services to support manufacturers, processors, farmers, and retailers; Clinical diagnostics services to patients, clinicians, and hospitals, and environmental regulatory services such as impact assessments and post project monitoring, to various industries, such as power and infrastructure.
More about the company
  1. Stock Market
  2. Equities
  3. VIMTALABS Stock
  4. News Vimta Labs Limited
  5. Vimta Labs Begins Operations of National Food Laboratory in Mumbai